Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.040
-0.200 (-16.13%)
Jan 16, 2026, 4:00 PM EST - Market closed
Gelteq Market Cap
Gelteq has a market cap or net worth of $11.14 million as of January 16, 2026. Its market cap has decreased by -49.13% in one year.
Market Cap
11.14M
Enterprise Value
13.68M
1-Year Change
-49.13%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since the IPO on October 29, 2024, Gelteq's market cap has decreased from $37.75M to $11.14M, a decrease of -70.49%. That is a compound annual growth rate of -63.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 11.14M | 30.00% |
| Dec 31, 2025 | 8.57M | -60.87% |
| Dec 31, 2024 | 21.90M | -42.00% |
| Oct 29, 2024 | 37.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |